NYTimes OP-Ed: Don’t Weaken the F.D.A.’s Drug Approval Process
An Op-Ed written by Gregg Gonsalves, Mark Harrington, and David A. Kessler.
An Op-Ed written by Gregg Gonsalves, Mark Harrington, and David A. Kessler.
May 2015 Examples of media coverage: Gilead Sciences (GILD) May Have Found A Cure For HIV! – CNA Finance, May 18, 2015 This Experimental Drug Could Finally Cure HIV – Motley Fool, May 18, 2015 Original source: Unknown, possibly a…
New York, NY– Governor Cuomo formally accepted the long-awaited Blueprint to End AIDS at a public event on Wednesday, marking an important step towards fulfilling his commitment to end AIDS in New York State.
TAG & Housing Works Report Shows Plan To End AIDS By 2020 Will Translate Into $4.5 Billion In Net Medicaid Savings For NY State.
Optimism is not without merit, but the science remains incredibly fragile By Richard Jefferys We’re pretty optimistic in this 15-year period we will get those two new tools. —Bill Gates, World Economic Forum, January 23, 2015 Earlier this year, Bill…
We won’t end HIV as an epidemic with anemic goals, delayed surveillance data, feeble support of state policies and resource needs, and an inadequate implementation science agenda By Kenyon Farrow The U.S. National HIV/AIDS Strategy (NHAS) ends its five-year run…
Not only is it the right thing to do for the health of New Yorkers, but a new analysis demonstrates that it is also cost-effective By Ginny Shubert, Housing Works; and Mark Harrington In June 2014, New York Governor Andrew…
By Tim Horn With growing recognition that science and discovery have forged the tools necessary to effectively diagnose, treat, and, indeed, eliminate three of the world’s most lethal infectious diseases—HIV/AIDS, tuberculosis, and hepatitis C—there is a need for greater mobilization…
On Targets and Timelines: With growing recognition that science and discovery have forged the tools necessary to effectively diagnose, treat, and, indeed, eliminate three of the world’s most lethal infectious diseases—HIV/AIDS, tuberculosis, and hepatitis C—there is a need for greater mobilization and strengthened accountability among all stakeholders.
Ending AIDS as an epidemic is not just the right thing to do for the health of New Yorkers – it’s also cost-effective. We simply can’t afford a status-quo approach to HIV.